Medical cannabis research

Nov 21, 2019

DEA Approves MMJ International Holdings THC Shipment for Multiple Sclerosis, Huntington's Disease Drug Development

Nov 21, 2019

INTERCURE: CANNDOC Initiates Phase 3 Clinical Trial Evaluating Pharma Grade Medicinal Cannabis (CANNDOC T1/C20) For Children With Autism Spectrum Disorder

Aug 20, 2019

MMJ International Holdings Shipping THC and CBD to US For Clinical Trials

Feb 13, 2019

MMJ Files FDA Fast Track Approval Application For Cannabis Multiple Sclerosis Drug

Feb 11, 2019

Compassionate Certification Centers at the Forefront of Medical Cannabis Research in Pennsylvania

Jan 29, 2019

FDA Awards MMJ International Holdings Orphan Drug Designation for Huntington's Cannabis Trial

Nov 20, 2018

Innovative Test Developed by Navigator Genomics for Medical Cannabis & Prescription Drugs

Oct 25, 2018

Groundbreaking Medical Research to Be Presented at CannaTech Sydney, Australia's First Summit to Accelerate Medical Cannabis Innovation

Oct 19, 2018

Cannabics Pharmaceuticals Announces Attendance at the CannMed 2018 Conference, Held at the UCLA Luskin Conference Center, Los Angeles, October 22-24

Oct 17, 2018

CannMed 2018, Country's Premier Medical Cannabis Conference, Opens October 22nd - 24th at UCLA Luskin Center

Aug 07, 2018

American Osteopathic Association Recommends Reclassification of Cannabis

Jul 26, 2018

Aphria Completes Largest Export Shipment to Date to Medlab Australia

Jun 13, 2018

International Cannabis Legalization to Spur Global Medical and Recreational Sales